A large new study from Canada adds to the conversation about cannabis and prescription drugs. Published Nov. 19 in the Journal of Psychiatric Research, it looked at Veterans Affairs Canada records for 116,815 veterans eligible for medical cannabis reimbursement between 2014 and 2020, The Marijuana Herald reports.
About 8.8% were authorized for medical cannabis. Veterans with PTSD were roughly six times more likely to take part (30% versus 5%).
Among veterans with PTSD, 47% of cannabis participants had antidepressant reimbursements, compared with 65% of nonparticipants. Antipsychotics were 17% versus 24%, and opioids 16% versus 19%. Across the wider group, cannabis authorization was linked to lower reimbursement rates for opioids, antidepressants, benzodiazepines and antipsychotics.
The program also grew fast, from 628 authorized veterans in 2014–15 to 15,369 in 2020–21.
Important caveats: the researchers say the data can't show that cannabis caused the drop. They looked at reimbursements, not actual use, and participants' overall prescription spending was actually higher.
What it means for travelers: If you take prescription medications, don't swap or stop anything on your own because of a study. Talk with your doctor, and remember that medical cannabis rules vary by state and country.






